Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Ovarian, Colorectal, or Appendiceal Cancer
Conditions: Peritoneal Carcinomatosis; Peritoneal Neoplasms; Ovarian Cancer; Ovarian Neoplasms; Colorectal Cancer; Colorectal Neoplasms; Appendiceal Cancer; Appendiceal Neoplasms Interventions: Drug: Paclitaxel; Drug: Nilotinib Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Appendix Cancer | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Nilotinib | Oral Cancer | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | Tasigna